Advertisement

Pharmacy

Mallinckrodt has agreed to pay $15.4 million to resolve whistleblower allegations that the drugmaker paid physicians illegal kickbacks to boost prescriptions of its pricey H.P. Acthar Gel, the U.S. Justice Department said.

The number of oncology treatments approved by the FDA has substantially increased in the past decade as part of an increasing effort to combat cancer, according to STAT.

Advertisement
Advertisement